| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 3.38e-17 | 17 | 173 | 10 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 3.38e-17 | 17 | 173 | 10 | GO:0019198 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | PALD1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ | 1.33e-14 | 103 | 173 | 15 | GO:0004725 |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | PALD1 PP2D1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ | 9.02e-12 | 189 | 173 | 16 | GO:0004721 |
| GeneOntologyMolecularFunction | phosphatase activity | PALD1 PP2D1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ | 4.35e-09 | 287 | 173 | 16 | GO:0016791 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | PALD1 PP2D1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ PLCE1 | 4.62e-08 | 386 | 173 | 17 | GO:0042578 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.60e-07 | 18 | 173 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RANBP2 ARHGAP24 RGPD8 LARS1 RGPD1 RASGEF1A RTKN TBC1D8B ECT2 MADD ARFGAP2 ARFGAP3 RGPD3 HERC1 IQGAP3 PLCE1 RGPD5 | 4.54e-07 | 507 | 173 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RANBP2 ARHGAP24 RGPD8 LARS1 RGPD1 RASGEF1A RTKN TBC1D8B ECT2 MADD ARFGAP2 ARFGAP3 RGPD3 HERC1 IQGAP3 PLCE1 RGPD5 | 4.54e-07 | 507 | 173 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 6.43e-07 | 20 | 173 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RANBP2 ARHGAP24 RGPD8 LARS1 RGPD1 TBC1D8B ECT2 ARFGAP2 ARFGAP3 RGPD3 IQGAP3 RGPD5 | 1.01e-06 | 279 | 173 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PPFIBP1 NCK1 PTPRT PPL CNTN6 PTPN6 FASN PTPRB DST PTPRD PTPRF PTPRM PLEC CDH6 CDH8 CDH9 SNX1 PACSIN2 FERMT3 | 1.17e-06 | 599 | 173 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PALD1 SGSH LARS1 PP2D1 PTPRT PTPN5 PTPN6 FASN IARS2 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ CES3 PLCE1 | 1.97e-06 | 807 | 173 | 22 | GO:0016788 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.85e-06 | 28 | 173 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | cadherin binding | PPFIBP1 NCK1 PTPRT PPL FASN PTPRB PTPRM PLEC CDH6 CDH8 CDH9 SNX1 PACSIN2 | 8.51e-06 | 339 | 173 | 13 | GO:0045296 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.40e-05 | 36 | 173 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.60e-05 | 37 | 173 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RANBP2 ARHGAP24 RGPD8 LARS1 RGPD1 DELE1 APOE TBC1D8B ECT2 NLRP3 MADD ARFGAP2 ARFGAP3 RGPD3 MMP16 IQGAP3 RGPD5 | 1.65e-05 | 656 | 173 | 18 | GO:0008047 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 7.12e-05 | 50 | 173 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 EPRS1 RANBP2 RGPD8 RGPD1 RTKN ECT2 RGPD3 IQGAP3 USP33 PLCE1 SORL1 | 7.42e-05 | 360 | 173 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | linoleoyl-CoA desaturase activity | 7.46e-05 | 2 | 173 | 2 | GO:0016213 | |
| GeneOntologyMolecularFunction | proline-tRNA ligase activity | 7.46e-05 | 2 | 173 | 2 | GO:0004827 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 NPM1 RANBP2 ARHGAP24 RGPD8 NLRP7 LARS1 RGPD1 RASGEF1A NCK1 DELE1 APOE RTKN TBC1D8B ECT2 PI15 NLRP3 MADD ARFGAP2 ARFGAP3 RGPD3 HERC1 MMP16 IQGAP3 PLCE1 SORL1 RGPD5 | 9.01e-05 | 1418 | 173 | 27 | GO:0030234 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCA3 ERCC3 EP400 DNAH10 MYH7B CHD8 CHD3 MSH3 NLRP3 DNAH1 DNAH12 CHD6 DDX60L DYNC1H1 DNAH11 | 9.12e-05 | 614 | 173 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 9.44e-05 | 53 | 173 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RANBP2 RGPD8 RGPD1 RTKN ECT2 RGPD3 IQGAP3 USP33 PLCE1 SORL1 | 1.17e-04 | 321 | 173 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.88e-04 | 37 | 173 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.54e-04 | 70 | 173 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 4.71e-04 | 42 | 173 | 4 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 4.71e-04 | 42 | 173 | 4 | GO:0004812 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ABCA3 ERCC3 DNAH10 CHD8 CHD3 NLRP3 DNAH12 CHD6 DDX60L DYNC1H1 DNAH11 | 4.80e-04 | 441 | 173 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.74e-04 | 118 | 173 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 6.27e-04 | 120 | 173 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | acyl-CoA desaturase activity | 7.34e-04 | 5 | 173 | 2 | GO:0016215 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.44e-04 | 127 | 173 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 1.44e-03 | 26 | 173 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | helicase activity | 2.57e-03 | 158 | 173 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase inhibitor activity | 2.58e-03 | 9 | 173 | 2 | GO:0019828 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | NUDT18 ABCC3 ABCA3 ERCC3 DNAH10 CHD8 CHD3 RAB40A NLRP3 DNAH12 RAB40AL EIF5B CHD6 DDX60L DYNC1H1 DNAH11 | 2.63e-03 | 839 | 173 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | NUDT18 ABCC3 ABCA3 ERCC3 DNAH10 CHD8 CHD3 RAB40A NLRP3 DNAH12 RAB40AL EIF5B CHD6 DDX60L DYNC1H1 DNAH11 | 2.67e-03 | 840 | 173 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | NUDT18 ABCC3 ABCA3 ERCC3 DNAH10 CHD8 CHD3 RAB40A NLRP3 DNAH12 RAB40AL EIF5B CHD6 DDX60L DYNC1H1 DNAH11 | 2.67e-03 | 840 | 173 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 ABCA3 ERCC3 DNAH10 CHD8 CHD3 RAB40A NLRP3 DNAH12 RAB40AL EIF5B CHD6 DDX60L DYNC1H1 DNAH11 | 3.11e-03 | 775 | 173 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.41e-03 | 35 | 173 | 3 | GO:0015020 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | NCK1 PP2D1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ | 6.25e-10 | 256 | 175 | 16 | GO:0006470 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 5.09e-09 | 9 | 175 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.01e-08 | 10 | 175 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.20e-08 | 20 | 175 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 1.24e-08 | 34 | 175 | 7 | GO:0035335 | |
| GeneOntologyBiologicalProcess | dephosphorylation | NCK1 PP2D1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ | 4.73e-08 | 347 | 175 | 16 | GO:0016311 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 5.06e-08 | 13 | 175 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 7.81e-08 | 14 | 175 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PTPRT CNTN6 PTPRD PTPRF PTPRG PTPRM PTPRR PTPRS PIK3CB TNFAIP3 IL1RAP CDH6 CDH8 CDH9 | 4.88e-07 | 313 | 175 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 6.10e-07 | 9 | 175 | 4 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 6.10e-07 | 9 | 175 | 4 | GO:0000912 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 1.01e-06 | 10 | 175 | 4 | GO:0044837 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.39e-06 | 42 | 175 | 6 | GO:0099560 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.63e-06 | 187 | 175 | 10 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CRISP2 ITCH HLA-DOB ETS1 NCK1 AQP4 PTPRT NLRP3 CNTN6 PTPN6 PTPRD PTPRF PTPRG PTPRM PTPRR PTPRS PIK3CB TNFAIP3 FGL1 IL1RAP CDH6 CDH8 CDH9 FERMT3 | 1.44e-05 | 1077 | 175 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.66e-05 | 38 | 175 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 2.05e-05 | 7 | 175 | 3 | GO:0007185 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 3.26e-05 | 8 | 175 | 3 | GO:0070980 | |
| GeneOntologyBiologicalProcess | cytokinetic process | 5.29e-05 | 48 | 175 | 5 | GO:0032506 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 6.47e-05 | 26 | 175 | 4 | GO:1904889 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 6.90e-05 | 10 | 175 | 3 | GO:1990264 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 6.90e-05 | 10 | 175 | 3 | GO:0018879 | |
| GeneOntologyBiologicalProcess | prolyl-tRNA aminoacylation | 7.16e-05 | 2 | 175 | 2 | GO:0006433 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.38e-05 | 54 | 175 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.25e-04 | 12 | 175 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | regulation of neurofibrillary tangle assembly | 2.14e-04 | 3 | 175 | 2 | GO:1902996 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RGPD4 NPM1 RANBP2 RGPD8 RGPD1 APOE ECT2 PTPRT AXIN2 NPFFR2 PTPN6 PTPRB RGPD3 PTPRQ TNFAIP3 PLEC | 2.55e-04 | 686 | 175 | 16 | GO:0043549 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.67e-04 | 195 | 175 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 NPM1 RANBP2 RGPD8 SYNE1 RGPD1 ECT2 PTPN5 UTP25 RGPD3 RGPD5 | 2.77e-04 | 362 | 175 | 11 | GO:0034504 |
| GeneOntologyBiologicalProcess | import into nucleus | 3.28e-04 | 201 | 175 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 3.44e-04 | 71 | 175 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid efflux | 4.25e-04 | 4 | 175 | 2 | GO:1902994 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid efflux | 4.25e-04 | 4 | 175 | 2 | GO:1902995 | |
| GeneOntologyBiologicalProcess | neurofibrillary tangle assembly | 4.25e-04 | 4 | 175 | 2 | GO:1902988 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 4.25e-04 | 4 | 175 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | tRNA aminoacylation for protein translation | 4.36e-04 | 42 | 175 | 4 | GO:0006418 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 5.69e-04 | 45 | 175 | 4 | GO:0030866 | |
| GeneOntologyBiologicalProcess | tRNA aminoacylation | 5.69e-04 | 45 | 175 | 4 | GO:0043039 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 6.15e-04 | 221 | 175 | 8 | GO:0006469 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 6.19e-04 | 46 | 175 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | amino acid activation | 6.19e-04 | 46 | 175 | 4 | GO:0043038 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.13e-09 | 8 | 175 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.46e-09 | 10 | 175 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 7.31e-08 | 14 | 175 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.05e-07 | 18 | 175 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 5.44e-07 | 20 | 175 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 7.09e-07 | 21 | 175 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear envelope | AKAP6 RGPD4 RANBP2 RGPD8 SYNE1 RGPD1 APOE RAB40A DST RGPD3 RAB40AL TMEM209 UGT2B10 UGT2B28 UGT2B11 DYNC1H1 SORL1 RGPD5 | 1.17e-06 | 560 | 175 | 18 | GO:0005635 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 RGPD4 RANBP2 RGPD8 SYNE1 RGPD1 SPIRE1 RAB40A USP20 EPG5 FZD9 DST PTPRM PTPRR RGPD3 RAB40AL UGT2B28 PLEC SNX1 USP33 SORL1 | 3.75e-05 | 934 | 175 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | inner dynein arm | 6.63e-05 | 10 | 175 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 NPM1 XIRP1 ARHGAP24 PPFIBP1 NCK1 ECT2 AQP4 PPL PTPN6 PTPRA DST PTPRM PLEC CDH6 CDH8 IQGAP3 CDH9 PACSIN2 USP33 FERMT3 | 7.05e-05 | 976 | 175 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | dynein complex | 8.81e-05 | 54 | 175 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 XIRP1 ARHGAP24 NCK1 ECT2 AQP4 PPL PTPN6 DST PTPRM CDH6 CDH8 IQGAP3 CDH9 PACSIN2 | 1.40e-04 | 591 | 175 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | nuclear pore | 2.07e-04 | 101 | 175 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 3.43e-04 | 40 | 175 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 6.39e-04 | 47 | 175 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | nuclear membrane | AKAP6 RGPD4 RANBP2 RGPD8 SYNE1 RGPD1 RGPD3 UGT2B10 UGT2B28 UGT2B11 | 7.43e-04 | 349 | 175 | 10 | GO:0031965 |
| GeneOntologyCellularComponent | organelle envelope | AKAP6 RGPD4 RANBP2 RGPD8 SYNE1 RGPD1 SPIRE1 DELE1 APOE RAB40A SLC25A25 FZD9 DST TK2 RGPD3 RAB40AL TMEM209 UGT2B10 UGT2B28 PLEC UGT2B11 DYNC1H1 SORL1 RGPD5 | 9.11e-04 | 1435 | 175 | 24 | GO:0031967 |
| GeneOntologyCellularComponent | inclusion body | 9.61e-04 | 90 | 175 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.16e-03 | 25 | 175 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | synaptic membrane | IL31RA SYNE1 HTR3C CHRNA4 PTPRT CNTN6 PTPN5 PTPRA PTPRD PTPRF PTPRS CDH8 CDH9 | 1.29e-03 | 583 | 175 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | catenin complex | 2.39e-03 | 32 | 175 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | granular component | 2.41e-03 | 9 | 175 | 2 | GO:0001652 | |
| MousePheno | abnormal blastocyst formation | 8.81e-08 | 39 | 137 | 7 | MP:0012128 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 3.37e-07 | 16 | 137 | 5 | MP:0003701 | |
| MousePheno | failure of blastocyst formation | 4.78e-07 | 31 | 137 | 6 | MP:0012129 | |
| MousePheno | abnormal morula morphology | 4.68e-06 | 26 | 137 | 5 | MP:0012058 | |
| MousePheno | decreased tumor latency | 9.83e-06 | 30 | 137 | 5 | MP:0010308 | |
| MousePheno | abnormal tumor latency | 1.86e-05 | 34 | 137 | 5 | MP:0010307 | |
| MousePheno | abnormal susceptibility to weight gain | RGPD4 EPRS1 RANBP2 RGPD8 RGPD1 SI APOE SLC25A25 NLRP3 NPFFR2 RGPD3 DYNC1H1 | 5.19e-05 | 309 | 137 | 12 | MP:0011117 |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 8.60e-05 | 107 | 137 | 7 | MP:0003694 | |
| MousePheno | increased lung carcinoma incidence | 1.14e-04 | 78 | 137 | 6 | MP:0008714 | |
| MousePheno | abnormal blastocyst hatching | 1.21e-04 | 113 | 137 | 7 | MP:0003693 | |
| MousePheno | embryonic lethality before implantation | 1.35e-04 | 242 | 137 | 10 | MP:0006204 | |
| MousePheno | increased circulating amylase level | 1.68e-04 | 119 | 137 | 7 | MP:0008806 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 1.74e-04 | 203 | 137 | 9 | MP:0011094 | |
| MousePheno | impaired glucose tolerance | RGPD4 PALD1 EPRS1 RANBP2 RGPD8 RGPD1 CHD8 APOE PIK3CB SLC20A2 RGPD3 FGL1 HERC1 DYNC1H1 | 2.61e-04 | 480 | 137 | 14 | MP:0005293 |
| MousePheno | abnormal preimplantation embryo development | 2.79e-04 | 171 | 137 | 8 | MP:0009781 | |
| Domain | PTPc | PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 4.49e-18 | 36 | 173 | 13 | SM00194 |
| Domain | TYR_PHOSPHATASE_PTP | PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 1.54e-17 | 39 | 173 | 13 | PS50055 |
| Domain | PTPase_domain | PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 3.29e-17 | 41 | 173 | 13 | IPR000242 |
| Domain | Y_phosphatase | PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 3.29e-17 | 41 | 173 | 13 | PF00102 |
| Domain | PTPc_motif | PALD1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 1.86e-16 | 59 | 173 | 14 | SM00404 |
| Domain | Tyr_Pase_cat | PALD1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 1.86e-16 | 59 | 173 | 14 | IPR003595 |
| Domain | - | PALD1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 1.35e-13 | 92 | 173 | 14 | 3.90.190.10 |
| Domain | Prot-tyrosine_phosphatase-like | PALD1 PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 3.86e-13 | 99 | 173 | 14 | IPR029021 |
| Domain | TYR_PHOSPHATASE_1 | PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 1.13e-12 | 86 | 173 | 13 | PS00383 |
| Domain | TYR_PHOSPHATASE_dom | PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 1.32e-12 | 87 | 173 | 13 | IPR000387 |
| Domain | TYR_PHOSPHATASE_2 | PTPRT PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 1.32e-12 | 87 | 173 | 13 | PS50056 |
| Domain | Tyr_Pase_AS | PTPRT PTPN5 PTPN6 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS | 3.06e-12 | 73 | 173 | 12 | IPR016130 |
| Domain | Ran_BP1 | 5.11e-10 | 12 | 173 | 6 | PF00638 | |
| Domain | RANBD1 | 5.11e-10 | 12 | 173 | 6 | PS50196 | |
| Domain | RanBD | 9.42e-10 | 13 | 173 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 9.42e-10 | 13 | 173 | 6 | IPR000156 | |
| Domain | Grip | 2.84e-08 | 11 | 173 | 5 | SM00755 | |
| Domain | GRIP | 2.84e-08 | 11 | 173 | 5 | PF01465 | |
| Domain | GRIP_dom | 4.84e-08 | 12 | 173 | 5 | IPR000237 | |
| Domain | GRIP | 4.84e-08 | 12 | 173 | 5 | PS50913 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.20e-07 | 14 | 173 | 5 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.20e-07 | 14 | 173 | 5 | IPR013602 | |
| Domain | DHC_N2 | 1.20e-07 | 14 | 173 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.20e-07 | 14 | 173 | 5 | IPR011704 | |
| Domain | AAA_8 | 1.20e-07 | 14 | 173 | 5 | PF12780 | |
| Domain | AAA_5 | 1.20e-07 | 14 | 173 | 5 | PF07728 | |
| Domain | DHC_fam | 1.79e-07 | 15 | 173 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 1.79e-07 | 15 | 173 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.79e-07 | 15 | 173 | 5 | IPR004273 | |
| Domain | Rab_bind | 2.44e-07 | 7 | 173 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.44e-07 | 7 | 173 | 4 | IPR032023 | |
| Domain | - | 1.43e-06 | 10 | 173 | 4 | 1.10.220.60 | |
| Domain | fn3 | IL31RA PTPRT CNTN6 PTPRB PTPRD PTPRF PTPRG PTPRM PTPRS SORL1 | 2.76e-06 | 162 | 173 | 10 | PF00041 |
| Domain | Dynein_HC_stalk | 6.62e-06 | 14 | 173 | 4 | IPR024743 | |
| Domain | MT | 6.62e-06 | 14 | 173 | 4 | PF12777 | |
| Domain | FN3 | IL31RA PTPRT CNTN6 PTPRB PTPRD PTPRF PTPRG PTPRM PTPRS SORL1 | 8.98e-06 | 185 | 173 | 10 | SM00060 |
| Domain | SPEC | 1.06e-05 | 32 | 173 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.06e-05 | 32 | 173 | 5 | IPR018159 | |
| Domain | P-loop_NTPase | ABCC3 ABCA3 ERCC3 EP400 NLRP7 DNAH10 MYH7B CHD8 CHD3 MSH3 RAB40A NLRP3 DNAH1 DNAH12 UTP25 TK2 RAB40AL EIF5B CHD6 DDX60L DYNC1H1 DNAH11 | 1.25e-05 | 848 | 173 | 22 | IPR027417 |
| Domain | FN3 | IL31RA PTPRT CNTN6 PTPRB PTPRD PTPRF PTPRG PTPRM PTPRS SORL1 | 1.70e-05 | 199 | 173 | 10 | PS50853 |
| Domain | - | ABCC3 ABCA3 ERCC3 EP400 NLRP7 DNAH10 CHD8 CHD3 MSH3 RAB40A DNAH1 DNAH12 UTP25 TK2 RAB40AL EIF5B CHD6 DDX60L DYNC1H1 DNAH11 | 2.00e-05 | 746 | 173 | 20 | 3.40.50.300 |
| Domain | FN3_dom | IL31RA PTPRT CNTN6 PTPRB PTPRD PTPRF PTPRG PTPRM PTPRS SORL1 | 2.59e-05 | 209 | 173 | 10 | IPR003961 |
| Domain | Plectin | 2.66e-05 | 7 | 173 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.66e-05 | 7 | 173 | 3 | IPR001101 | |
| Domain | PLEC | 2.66e-05 | 7 | 173 | 3 | SM00250 | |
| Domain | DHC_N1 | 4.23e-05 | 8 | 173 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 4.23e-05 | 8 | 173 | 3 | IPR013594 | |
| Domain | Pro-tRNA-ligase_IIa | 8.53e-05 | 2 | 173 | 2 | IPR002316 | |
| Domain | Nop52 | 8.53e-05 | 2 | 173 | 2 | IPR010301 | |
| Domain | Tyr_Pase_rcpt_a/e-type | 8.53e-05 | 2 | 173 | 2 | IPR016336 | |
| Domain | Tyr_Pase_rcpt_R/non-rcpt_5 | 8.53e-05 | 2 | 173 | 2 | IPR016334 | |
| Domain | Nop52 | 8.53e-05 | 2 | 173 | 2 | PF05997 | |
| Domain | Spectrin_repeat | 1.41e-04 | 29 | 173 | 4 | IPR002017 | |
| Domain | TPR_REGION | 1.54e-04 | 165 | 173 | 8 | PS50293 | |
| Domain | TPR | 1.54e-04 | 165 | 173 | 8 | PS50005 | |
| Domain | PH_dom-like | RGPD4 RANBP2 ARHGAP24 RGPD8 RGPD1 RTKN ECT2 RTKN2 PTPN13 RGPD3 FERMT3 PLCE1 RGPD5 | 1.75e-04 | 426 | 173 | 13 | IPR011993 |
| Domain | SNF2_N | 2.09e-04 | 32 | 173 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.09e-04 | 32 | 173 | 4 | PF00176 | |
| Domain | AHD | 2.54e-04 | 3 | 173 | 2 | IPR012966 | |
| Domain | Anillin | 2.54e-04 | 3 | 173 | 2 | PF08174 | |
| Domain | Fatty_acid_desaturase | 2.54e-04 | 3 | 173 | 2 | IPR012171 | |
| Domain | Tyr_Pase_KIM-con | 2.54e-04 | 3 | 173 | 2 | IPR008356 | |
| Domain | - | RGPD4 RANBP2 ARHGAP24 RGPD8 RGPD1 RTKN ECT2 RTKN2 PTPN13 RGPD3 FERMT3 PLCE1 | 2.95e-04 | 391 | 173 | 12 | 2.30.29.30 |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.97e-04 | 35 | 173 | 4 | IPR002464 | |
| Domain | CH | 3.39e-04 | 65 | 173 | 5 | SM00033 | |
| Domain | - | 4.00e-04 | 16 | 173 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.00e-04 | 16 | 173 | 3 | SM00146 | |
| Domain | DEAH_ATP_HELICASE | 4.10e-04 | 38 | 173 | 4 | PS00690 | |
| Domain | CH | 4.79e-04 | 70 | 173 | 5 | PF00307 | |
| Domain | Helicase_C | 4.83e-04 | 107 | 173 | 6 | PF00271 | |
| Domain | HELICc | 4.83e-04 | 107 | 173 | 6 | SM00490 | |
| Domain | GPR107-like | 5.06e-04 | 4 | 173 | 2 | IPR009637 | |
| Domain | Lung_7-TM_R | 5.06e-04 | 4 | 173 | 2 | PF06814 | |
| Domain | Helicase_C | 5.08e-04 | 108 | 173 | 6 | IPR001650 | |
| Domain | - | 5.11e-04 | 71 | 173 | 5 | 1.10.418.10 | |
| Domain | HELICASE_CTER | 5.33e-04 | 109 | 173 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.33e-04 | 109 | 173 | 6 | PS51192 | |
| Domain | DEXDc | 5.33e-04 | 109 | 173 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.60e-04 | 110 | 173 | 6 | IPR014001 | |
| Domain | aa-tRNA-synth_I_CS | 5.75e-04 | 18 | 173 | 3 | IPR001412 | |
| Domain | PI3_PI4_kinase | 5.75e-04 | 18 | 173 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.75e-04 | 18 | 173 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.75e-04 | 18 | 173 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.75e-04 | 18 | 173 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.75e-04 | 18 | 173 | 3 | PS50290 | |
| Domain | CH | 5.81e-04 | 73 | 173 | 5 | PS50021 | |
| Domain | CH-domain | 6.58e-04 | 75 | 173 | 5 | IPR001715 | |
| Domain | PRAME_family | 6.79e-04 | 19 | 173 | 3 | IPR026271 | |
| Domain | AA_TRNA_LIGASE_I | 6.79e-04 | 19 | 173 | 3 | PS00178 | |
| Domain | KIND_dom | 8.38e-04 | 5 | 173 | 2 | IPR011019 | |
| Domain | KIND | 8.38e-04 | 5 | 173 | 2 | SM00750 | |
| Domain | KIND | 8.38e-04 | 5 | 173 | 2 | PS51377 | |
| Domain | UDPGT | 9.19e-04 | 21 | 173 | 3 | PF00201 | |
| Domain | UDPGT | 9.19e-04 | 21 | 173 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 9.19e-04 | 21 | 173 | 3 | IPR002213 | |
| Domain | ACTININ_2 | 1.21e-03 | 23 | 173 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.21e-03 | 23 | 173 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.21e-03 | 23 | 173 | 3 | IPR001589 | |
| Domain | BRK | 1.25e-03 | 6 | 173 | 2 | SM00592 | |
| Domain | - | 1.25e-03 | 6 | 173 | 2 | 3.90.1290.10 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 6.24e-07 | 18 | 137 | 5 | MM1549 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.11e-06 | 20 | 137 | 5 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.11e-06 | 20 | 137 | 5 | MM14991 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.03e-05 | 40 | 137 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.56e-05 | 41 | 137 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.13e-05 | 42 | 137 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.76e-05 | 43 | 137 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.90e-05 | 47 | 137 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.09e-04 | 49 | 137 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.20e-04 | 50 | 137 | 5 | MM14610 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.26e-04 | 27 | 137 | 4 | M47755 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.32e-04 | 51 | 137 | 5 | MM15151 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.34e-04 | 155 | 137 | 8 | M522 | |
| Pathway | WP_ELONGATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS | 1.85e-04 | 12 | 137 | 3 | MM17077 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.90e-04 | 55 | 137 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.44e-04 | 58 | 137 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.44e-04 | 58 | 137 | 5 | MM14736 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 3.02e-04 | 14 | 137 | 3 | M39780 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 3.02e-04 | 14 | 137 | 3 | MM15840 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 3.42e-04 | 96 | 137 | 6 | MM14592 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.17e-04 | 65 | 137 | 5 | MM15147 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 4.26e-04 | 100 | 137 | 6 | MM14561 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 4.80e-04 | 67 | 137 | 5 | MM15327 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.39e-04 | 39 | 137 | 4 | MM15695 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RANBP2 ARHGAP24 RGPD8 RGPD1 NCK1 RTKN ECT2 TMEM87A SLC1A5 PTPN13 DST ARFGAP3 RGPD3 IQGAP3 DYNC1H1 | 5.61e-04 | 649 | 137 | 16 | MM15690 |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.54e-04 | 41 | 137 | 4 | M7399 | |
| Pathway | KEGG_AMINOACYL_TRNA_BIOSYNTHESIS | 6.54e-04 | 41 | 137 | 4 | M14691 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 7.13e-04 | 73 | 137 | 5 | MM15126 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 7.13e-04 | 73 | 137 | 5 | MM14948 | |
| Pathway | REACTOME_TRNA_AMINOACYLATION | 7.18e-04 | 42 | 137 | 4 | M456 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 7.85e-04 | 43 | 137 | 4 | M47669 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.57e-04 | 44 | 137 | 4 | M45014 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 9.07e-04 | 20 | 137 | 3 | MM15485 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 9.12e-04 | 257 | 137 | 9 | MM14755 | |
| Pathway | WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM | 9.20e-04 | 5 | 137 | 2 | M48057 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 9.34e-04 | 45 | 137 | 4 | M47670 | |
| Pathway | REACTOME_ASPIRIN_ADME | 9.34e-04 | 45 | 137 | 4 | MM15694 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 9.77e-04 | 117 | 137 | 6 | MM15387 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.05e-03 | 21 | 137 | 3 | M27736 | |
| Pathway | REACTOME_INTERLEUKIN_37_SIGNALING | 1.05e-03 | 21 | 137 | 3 | M27873 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.21e-03 | 82 | 137 | 5 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.35e-03 | 84 | 137 | 5 | MM14929 | |
| Pathway | WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2 | 1.37e-03 | 6 | 137 | 2 | M42575 | |
| Pathway | WP_METABOLISM_OF_ALPHALINOLENIC_ACID | 1.37e-03 | 6 | 137 | 2 | M39844 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.38e-03 | 23 | 137 | 3 | MM16639 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 GOLGA8R NCK1 RTKN ECT2 TMEM87A SLC1A5 ARFGAP2 PTPN13 DST ARFGAP3 IQGAP3 | 1.46e-03 | 450 | 137 | 12 | M27078 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.49e-03 | 86 | 137 | 5 | MM15413 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.50e-03 | 51 | 137 | 4 | M17726 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.57e-03 | 24 | 137 | 3 | MM14599 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.57e-03 | 87 | 137 | 5 | M27617 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.61e-03 | 52 | 137 | 4 | M14171 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.62e-03 | 129 | 137 | 6 | MM14894 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.77e-03 | 25 | 137 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.77e-03 | 25 | 137 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.77e-03 | 25 | 137 | 3 | M605 | |
| Pubmed | 1.19e-19 | 11 | 180 | 9 | 7832766 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.03e-14 | 17 | 180 | 8 | 19727691 | |
| Pubmed | 1.23e-13 | 7 | 180 | 6 | 12376545 | ||
| Pubmed | 1.23e-13 | 7 | 180 | 6 | 1454056 | ||
| Pubmed | 3.51e-12 | 5 | 180 | 5 | 10777529 | ||
| Pubmed | Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. | 2.10e-11 | 6 | 180 | 5 | 2170109 | |
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 9037092 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 21205196 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 24403063 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 23536549 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 12191015 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 7.31e-11 | 7 | 180 | 5 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 7.31e-11 | 7 | 180 | 5 | 11353387 | |
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 30944974 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 7.31e-11 | 7 | 180 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 7.31e-11 | 7 | 180 | 5 | 17372272 | |
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 38657106 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 18949001 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 25187515 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 8603673 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 26632511 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 23818861 | ||
| Pubmed | 7.31e-11 | 7 | 180 | 5 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.94e-10 | 8 | 180 | 5 | 21670213 | |
| Pubmed | 1.94e-10 | 8 | 180 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.94e-10 | 8 | 180 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.94e-10 | 8 | 180 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.94e-10 | 8 | 180 | 5 | 28745977 | |
| Pubmed | 4.35e-10 | 9 | 180 | 5 | 28100513 | ||
| Pubmed | 4.35e-10 | 9 | 180 | 5 | 17887960 | ||
| Pubmed | 4.35e-10 | 9 | 180 | 5 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 4.35e-10 | 9 | 180 | 5 | 18394993 | |
| Pubmed | 4.35e-10 | 9 | 180 | 5 | 11553612 | ||
| Pubmed | 4.35e-10 | 9 | 180 | 5 | 10601307 | ||
| Pubmed | 4.35e-10 | 9 | 180 | 5 | 28877029 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MPO ITCH PRAMEF5 PRAMEF20 ETS1 ECT2 SLC7A2 MAB21L3 DST EIF5B CHD6 PLEC CDH6 PRAMEF6 USP33 | 8.51e-10 | 363 | 180 | 15 | 14691545 |
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 8.67e-10 | 10 | 180 | 5 | 16332688 | |
| Pubmed | 8.67e-10 | 10 | 180 | 5 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 8.67e-10 | 10 | 180 | 5 | 8857542 | |
| Pubmed | 8.67e-10 | 10 | 180 | 5 | 21859863 | ||
| Pubmed | 1.58e-09 | 11 | 180 | 5 | 17069463 | ||
| Pubmed | 1.58e-09 | 11 | 180 | 5 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.58e-09 | 11 | 180 | 5 | 35771867 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 2.70e-09 | 12 | 180 | 5 | 9624153 | |
| Pubmed | 3.46e-09 | 5 | 180 | 4 | 22357843 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 4.37e-09 | 13 | 180 | 5 | 31427429 | |
| Pubmed | 6.77e-09 | 14 | 180 | 5 | 9373155 | ||
| Pubmed | 1.01e-08 | 15 | 180 | 5 | 14697343 | ||
| Pubmed | NPM1 RANBP2 COPA COPB1 RRP1B U2SURP CHD8 TTF1 TRRAP RRP1 FASN IARS2 DST UTP25 EIF5B WDR12 PLEC DYNC1H1 | 1.01e-08 | 653 | 180 | 18 | 22586326 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PPFIBP1 SLC1A5 PTPN13 PTPRA DST PTPRF SLC12A4 PTPRG PTPRM PTPRS SLC20A2 IL1RAP PACSIN2 FERMT3 | 1.23e-08 | 377 | 180 | 14 | 38117590 |
| Pubmed | 1.46e-08 | 16 | 180 | 5 | 8875997 | ||
| Pubmed | Expression of protein tyrosine phosphatase genes in the developing brain of mouse and rat. | 2.40e-08 | 7 | 180 | 4 | 7804149 | |
| Pubmed | AKAP6 EPRS1 ITCH COPA COPB1 PPFIBP1 SYNE1 LARS1 NCK1 MSH3 ARMCX4 APOE BRWD3 MADD PTPN13 PTPRA DST PTPRD MICAL2 CHD6 PLEC SNX1 DYNC1H1 USP33 | 5.94e-08 | 1285 | 180 | 24 | 35914814 | |
| Pubmed | 8.61e-08 | 22 | 180 | 5 | 27717094 | ||
| Pubmed | 1.36e-07 | 3 | 180 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.36e-07 | 3 | 180 | 3 | 33656439 | |
| Pubmed | 1.36e-07 | 3 | 180 | 3 | 9784606 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.36e-07 | 3 | 180 | 3 | 31985401 | |
| Pubmed | 1.36e-07 | 3 | 180 | 3 | 1655529 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 1.59e-07 | 47 | 180 | 6 | 19167335 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EPRS1 RANBP2 EP400 COPB1 RRP1B U2SURP LARS1 CHD8 CHD3 MSH3 TRRAP RRP1 WDR12 | 1.62e-07 | 394 | 180 | 13 | 27248496 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NPM1 EPRS1 RANBP2 EP400 COPA LARS1 CHD8 CHD3 MSH3 FASN PLEC DYNC1H1 | 1.86e-07 | 332 | 180 | 12 | 32786267 |
| Pubmed | NPM1 PALD1 EPRS1 RANBP2 COPA COPB1 PPFIBP1 LARS1 NCK1 SLC1A5 ARFGAP2 FASN PTPN13 DST EIF5B DYNC1H1 PACSIN2 | 1.90e-07 | 708 | 180 | 17 | 39231216 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 2.95e-07 | 171 | 180 | 9 | 20201926 | |
| Pubmed | PALD1 RANBP2 PPFIBP1 NCK1 TMEM87A ARFGAP2 SLC7A2 FASN DST SLC12A4 ARFGAP3 RGPD3 TMEM209 SNX1 USP33 | 3.12e-07 | 568 | 180 | 15 | 37774976 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NPM1 EPRS1 RANBP2 EP400 COPA COPB1 RRP1B SYNE1 U2SURP LARS1 CHD3 TRRAP SLC1A5 RRP1 FASN DST PTPRF EIF5B PLEC DYNC1H1 | 4.10e-07 | 1024 | 180 | 20 | 24711643 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 4.59e-07 | 235 | 180 | 10 | 30258100 | |
| Pubmed | IQCF5 RGPD4 NPM1 SMG1 EPRS1 RANBP2 RGPD8 NLRP7 COPA MYH7B SYNE1 U2SURP RGPD1 CHD3 PPL FASN DST SLC12A4 RGPD3 CES3 EIF5B CHD6 PLEC RGPD5 | 4.83e-07 | 1442 | 180 | 24 | 35575683 | |
| Pubmed | 5.43e-07 | 4 | 180 | 3 | 8524829 | ||
| Pubmed | 5.43e-07 | 4 | 180 | 3 | 14967925 | ||
| Pubmed | 5.43e-07 | 4 | 180 | 3 | 8759740 | ||
| Pubmed | 5.43e-07 | 4 | 180 | 3 | 9480752 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RANBP2 ERCC3 RGPD8 COPB1 RGPD1 CHD8 ARFGAP2 FASN RGPD3 PLEC DYNC1H1 | 5.90e-07 | 370 | 180 | 12 | 22922362 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MPO NPM1 EPRS1 RANBP2 ERCC3 ITCH EP400 COPA COPB1 U2SURP LARS1 CHD8 MSH3 ECT2 TRRAP SLC1A5 FASN DST MICAL2 EIF5B DDX60L PLEC DYNC1H1 | 5.96e-07 | 1353 | 180 | 23 | 29467282 |
| Pubmed | RANBP2 COPA RRP1B SLC1A5 PTPRT MADD PTPN5 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF SLC12A4 PTPRG PTPRM PTPRR PTPRS HERC1 | 5.97e-07 | 1049 | 180 | 20 | 27880917 | |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 8.54e-07 | 62 | 180 | 6 | 26508657 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 9.99e-07 | 256 | 180 | 10 | 33397691 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 COPA COPB1 SYNE1 LARS1 CHD8 SLC1A5 EPG5 DNAH1 RTKN2 FASN IARS2 DST EIF5B PLEC IQGAP3 DYNC1H1 | 1.16e-06 | 807 | 180 | 17 | 30575818 |
| Pubmed | 1.19e-06 | 202 | 180 | 9 | 24639526 | ||
| Pubmed | 1.20e-06 | 16 | 180 | 4 | 18308476 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 ABCC3 EP400 SPIRE1 CHD8 TRRAP SLC1A5 MADD FASN DST PTPRF SLC12A4 PTPRS USP40 ZER1 TNFAIP3 PLEC HERC1 IQGAP3 DYNC1H1 | 1.33e-06 | 1105 | 180 | 20 | 35748872 |
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 2169617 | ||
| Pubmed | Identification of protein tyrosine phosphatases expressed in murine male germ cells. | 1.35e-06 | 5 | 180 | 3 | 8267598 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.53e-06 | 38 | 180 | 5 | 12791264 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ABCC3 ITCH PPFIBP1 TMEM87A SLC1A5 SLC7A2 PTPRA PTPRF SLC12A4 PTPRG PTPRM MICAL2 SLC20A2 PACSIN2 | 1.80e-06 | 569 | 180 | 14 | 30639242 |
| Pubmed | RGPD4 RANBP2 RGPD8 RGPD1 CHD8 CHD3 FASN PTPN13 DST RGPD3 CHD6 PLEC | 2.10e-06 | 418 | 180 | 12 | 34709266 | |
| Pubmed | 2.21e-06 | 162 | 180 | 8 | 25826454 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NPM1 EPRS1 ERCC3 COPA COPB1 RRP1B SYNE1 U2SURP LARS1 ECT2 RRP1 FASN DST EIF5B TNFAIP3 PLEC MCTP2 DYNC1H1 | 2.43e-06 | 949 | 180 | 18 | 36574265 |
| Pubmed | 2.70e-06 | 6 | 180 | 3 | 19273906 | ||
| Pubmed | 2.70e-06 | 6 | 180 | 3 | 16273344 | ||
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 2.70e-06 | 6 | 180 | 3 | 21126580 | |
| Pubmed | SMG1 CHD3 TTF1 PPL EPG5 DST PTPRF SLC12A4 CHD6 TNFAIP3 PLEC HERC1 IL1RAP DYNC1H1 | 2.79e-06 | 591 | 180 | 14 | 15231748 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 2.89e-06 | 168 | 180 | 8 | 30631154 | |
| Pubmed | Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability. | 3.59e-06 | 122 | 180 | 7 | 31615875 | |
| Pubmed | 4.42e-06 | 237 | 180 | 9 | 29564676 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 4.63e-06 | 179 | 180 | 8 | 36261009 | |
| Pubmed | Characterization of cadherins expressed by murine thymocytes. | 4.70e-06 | 7 | 180 | 3 | 8620560 | |
| Pubmed | Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. | 4.70e-06 | 7 | 180 | 3 | 15978577 | |
| Interaction | PTPRS interactions | CHD3 PTPN6 PTPN13 PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRS PTPRQ IL1RAP | 7.92e-10 | 153 | 174 | 13 | int:PTPRS |
| Interaction | PTPRQ interactions | 1.34e-09 | 25 | 174 | 7 | int:PTPRQ | |
| Interaction | RGPD4 interactions | 2.53e-08 | 22 | 174 | 6 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 9.68e-08 | 27 | 174 | 6 | int:RGPD2 | |
| Interaction | PTPRA interactions | PTPN5 PTPN6 PTPN13 PTPRA PTPRD PTPRE PTPRF PTPRG PTPRM PTPRS PTPRQ | 1.90e-07 | 164 | 174 | 11 | int:PTPRA |
| Interaction | PTPRM interactions | 1.97e-07 | 72 | 174 | 8 | int:PTPRM | |
| Interaction | CTNNB1 interactions | NPM1 RANBP2 ARHGAP24 EP400 COPA LARS1 CHD8 APOE ECT2 TRRAP USP20 AXIN2 PTPN6 PTPN13 PTPRA DST PTPRF PTPRM PTPRQ CHD6 TNFAIP3 CDH6 CDH8 CDH9 DYNC1H1 USP33 | 5.76e-07 | 1009 | 174 | 26 | int:CTNNB1 |
| Interaction | PTPN13 interactions | RTKN PTPN6 PTPN13 PTPRA PTPRB PTPRE PTPRF PTPRG PTPRM PTPRS PTPRQ | 1.51e-06 | 202 | 174 | 11 | int:PTPN13 |
| Interaction | RHOU interactions | ABCA3 ITCH PPFIBP1 NCK1 RAB40A SLC1A5 CHRNA4 SLC7A2 PTPN13 FADS1 DST PTPRF SLC12A4 PTPRG PTPRS SLC20A2 PACSIN2 | 2.18e-06 | 510 | 174 | 17 | int:RHOU |
| Interaction | PTPRE interactions | 2.18e-06 | 69 | 174 | 7 | int:PTPRE | |
| Interaction | RGPD3 interactions | 3.04e-06 | 47 | 174 | 6 | int:RGPD3 | |
| Interaction | RHOC interactions | ITCH PPFIBP1 RTKN ECT2 TMEM87A SLC1A5 RTKN2 SLC7A2 PTPN13 PTPRF SLC12A4 PTPRS SLC20A2 TMEM209 IL1RAP MCTP2 IQGAP3 USP33 | 3.24e-06 | 584 | 174 | 18 | int:RHOC |
| Interaction | RGPD1 interactions | 3.91e-06 | 49 | 174 | 6 | int:RGPD1 | |
| Interaction | PTPRB interactions | 4.96e-06 | 51 | 174 | 6 | int:PTPRB | |
| Interaction | RND2 interactions | ITCH PPFIBP1 TMEM87A SLC1A5 SLC7A2 PTPN13 FADS1 DST PTPRF SLC12A4 PTPRG PTPRS SLC20A2 TMEM209 PACSIN2 | 6.78e-06 | 440 | 174 | 15 | int:RND2 |
| Interaction | RHOQ interactions | PALD1 ITCH COPB1 PPFIBP1 SLC1A5 SLC7A2 PTPN13 DST PTPRF SLC12A4 PTPRG PTPRS SLC20A2 IQGAP3 PACSIN2 | 7.15e-06 | 442 | 174 | 15 | int:RHOQ |
| Interaction | RHOH interactions | ITCH PPFIBP1 TMEM87A SLC1A5 SLC7A2 PTPN13 FADS1 DST PTPRF SLC12A4 PTPRG PTPRS SLC20A2 TMEM209 PACSIN2 SORL1 | 9.88e-06 | 512 | 174 | 16 | int:RHOH |
| Interaction | TMEM17 interactions | PALD1 COPA PPFIBP1 TMEM87A SLC1A5 ARFGAP2 SLC7A2 PTPN13 DST SLC12A4 ARFGAP3 SLC20A2 TMEM209 PACSIN2 | 1.16e-05 | 404 | 174 | 14 | int:TMEM17 |
| Interaction | RHOB interactions | PALD1 ITCH PPFIBP1 RTKN ECT2 TMEM87A SLC1A5 RTKN2 SLC7A2 PTPN13 PTPRF SLC12A4 PTPRG PTPRM PTPRS SLC20A2 TMEM209 HERC1 IL1RAP IQGAP3 PACSIN2 | 1.23e-05 | 840 | 174 | 21 | int:RHOB |
| Interaction | PTPRU interactions | 1.24e-05 | 124 | 174 | 8 | int:PTPRU | |
| Interaction | UGT2B28 interactions | 1.24e-05 | 6 | 174 | 3 | int:UGT2B28 | |
| Interaction | MCAM interactions | NPM1 PPFIBP1 SLC1A5 PTPN13 PTPRA DST PTPRF SLC12A4 PTPRG PTPRM PTPRS SLC20A2 IL1RAP PACSIN2 FERMT3 | 1.41e-05 | 468 | 174 | 15 | int:MCAM |
| Interaction | NPIPB6 interactions | 1.49e-05 | 18 | 174 | 4 | int:NPIPB6 | |
| Interaction | RGPD5 interactions | 1.98e-05 | 96 | 174 | 7 | int:RGPD5 | |
| Interaction | KCNA3 interactions | NPM1 PALD1 EPRS1 RANBP2 COPA COPB1 MYH7B PPFIBP1 LARS1 NCK1 SLC1A5 PPL ARFGAP2 FASN PTPN13 DST EIF5B IQGAP3 DYNC1H1 PACSIN2 SORL1 | 2.11e-05 | 871 | 174 | 21 | int:KCNA3 |
| Interaction | NTRK2 interactions | 2.29e-05 | 176 | 174 | 9 | int:NTRK2 | |
| Interaction | PTPN3 interactions | 2.58e-05 | 100 | 174 | 7 | int:PTPN3 | |
| Interaction | CDC42 interactions | PALD1 EPRS1 ERCC3 ITCH COPA PPFIBP1 SYNE1 LARS1 GOLGA8R MSH3 ECT2 TRRAP TMEM87A SLC1A5 ARFGAP2 SLC7A2 PTPN13 FADS1 PTPRF SLC12A4 PTPRS ARFGAP3 SLC20A2 TMEM209 EIF5B IQGAP3 PACSIN2 | 2.61e-05 | 1323 | 174 | 27 | int:CDC42 |
| Interaction | PTPRF interactions | TRRAP PTPN6 PTPN13 PTPRA PTPRD PTPRF PTPRM PTPRS PTPRQ IL1RAP | 3.63e-05 | 233 | 174 | 10 | int:PTPRF |
| Interaction | IL1RAP interactions | 3.75e-05 | 44 | 174 | 5 | int:IL1RAP | |
| Interaction | CDH1 interactions | PPFIBP1 NCK1 ECT2 TMEM87A SLC1A5 PPL ARFGAP2 FASN DST PTPRD PTPRF PTPRG PTPRM PTPRS PTPRQ PLEC CDH8 SNX1 PACSIN2 | 3.79e-05 | 768 | 174 | 19 | int:CDH1 |
| Interaction | GJD3 interactions | PALD1 COPA PPFIBP1 SYNE1 TMEM87A SLC1A5 ARFGAP2 SLC7A2 PTPN13 DST ARFGAP3 SLC20A2 TMEM209 USP33 | 4.18e-05 | 454 | 174 | 14 | int:GJD3 |
| Interaction | RGPD8 interactions | 4.33e-05 | 74 | 174 | 6 | int:RGPD8 | |
| Interaction | GJA1 interactions | ITCH COPA PPFIBP1 HTR3C TMEM87A SLC1A5 CHRNA4 ARFGAP2 IARS2 PTPN13 DST TSPAN31 SLC12A4 PTPRG ARFGAP3 TMEM209 | 4.78e-05 | 583 | 174 | 16 | int:GJA1 |
| Interaction | ARF6 interactions | PALD1 COPB1 PPFIBP1 ECT2 TMEM87A SLC1A5 SLC7A2 IARS2 PTPRF SLC12A4 PTPRG SLC20A2 TMEM209 SNX1 DYNC1H1 PACSIN2 | 4.88e-05 | 584 | 174 | 16 | int:ARF6 |
| Interaction | SIRT7 interactions | NPM1 RANBP2 COPA COPB1 RRP1B U2SURP CHD8 TTF1 TRRAP RRP1 FASN IARS2 DST UTP25 EIF5B WDR12 PLEC DYNC1H1 | 8.13e-05 | 744 | 174 | 18 | int:SIRT7 |
| Interaction | LINC00839 interactions | 8.27e-05 | 83 | 174 | 6 | int:LINC00839 | |
| Interaction | SPDL1 interactions | NPM1 PALD1 EPRS1 COPA U2SURP LARS1 MSH3 TRRAP FASN FADS2 PLEC | 9.59e-05 | 315 | 174 | 11 | int:SPDL1 |
| Interaction | DIRAS3 interactions | PPFIBP1 TMEM87A SLC1A5 SLC7A2 PTPN13 DST SLC12A4 PTPRG HERC1 PACSIN2 | 9.68e-05 | 262 | 174 | 10 | int:DIRAS3 |
| Interaction | RYK interactions | 9.73e-05 | 212 | 174 | 9 | int:RYK | |
| Interaction | RHOA interactions | PALD1 ITCH ERAP1 PPFIBP1 RTKN ECT2 TRRAP TMEM87A SLC1A5 SLC7A2 PTPN13 FADS1 PTPRF SLC12A4 PTPRG PTPRS ARFGAP3 SLC20A2 TMEM209 MCTP2 IQGAP3 SNX1 PACSIN2 USP33 | 1.04e-04 | 1199 | 174 | 24 | int:RHOA |
| Interaction | PPFIA3 interactions | 1.32e-04 | 57 | 174 | 5 | int:PPFIA3 | |
| Interaction | RHOD interactions | PALD1 ITCH PPFIBP1 GOLGA8R TMEM87A SLC1A5 SLC7A2 PTPN13 FADS1 PTPRF SLC12A4 SLC20A2 TMEM209 IQGAP3 PACSIN2 | 1.37e-04 | 572 | 174 | 15 | int:RHOD |
| Interaction | PTPN2 interactions | 1.43e-04 | 223 | 174 | 9 | int:PTPN2 | |
| Interaction | LAMP1 interactions | ARHGAP24 PPFIBP1 TRRAP TMEM87A SLC1A5 PARS2 SLC7A2 PTPN13 DST PTPRG PIK3CB SLC20A2 TMEM209 TNFAIP3 SNX1 PACSIN2 | 1.52e-04 | 644 | 174 | 16 | int:LAMP1 |
| Interaction | KPNA4 interactions | 1.53e-04 | 225 | 174 | 9 | int:KPNA4 | |
| Interaction | PHLPP1 interactions | EPRS1 RANBP2 COPB1 CHD3 AQP4 SLC1A5 FASN EIF5B PLEC SNX1 DYNC1H1 | 1.56e-04 | 333 | 174 | 11 | int:PHLPP1 |
| Interaction | RAPGEF5 interactions | 1.68e-04 | 60 | 174 | 5 | int:RAPGEF5 | |
| Interaction | OMG interactions | 1.70e-04 | 13 | 174 | 3 | int:OMG | |
| Interaction | LAMTOR1 interactions | PALD1 ITCH PPFIBP1 TMEM87A SLC1A5 NLRP3 SLC7A2 IARS2 DST PTPRD PTPRF SLC12A4 PTPRG ARFGAP3 SLC20A2 SNX1 PACSIN2 | 1.78e-04 | 722 | 174 | 17 | int:LAMTOR1 |
| Interaction | CCDC8 interactions | NPM1 EPRS1 RANBP2 EP400 COPA COPB1 RRP1B LARS1 CHD3 SLC1A5 FASN DNAH12 DST PLEC UGT2B11 DYNC1H1 | 1.87e-04 | 656 | 174 | 16 | int:CCDC8 |
| Interaction | COL17A1 interactions | 2.03e-04 | 34 | 174 | 4 | int:COL17A1 | |
| Interaction | POLR1E interactions | RANBP2 RRP1B CHD8 TTF1 TRRAP RRP1 FASN UTP25 POLR3E EIF5B CHD6 | 2.40e-04 | 350 | 174 | 11 | int:POLR1E |
| Interaction | PTPRG interactions | 2.58e-04 | 102 | 174 | 6 | int:PTPRG | |
| Interaction | ETAA1 interactions | 2.69e-04 | 145 | 174 | 7 | int:ETAA1 | |
| Interaction | PPFIA2 interactions | 2.84e-04 | 37 | 174 | 4 | int:PPFIA2 | |
| Interaction | RND1 interactions | 2.96e-04 | 246 | 174 | 9 | int:RND1 | |
| Interaction | TMEM216 interactions | PALD1 COPB1 TMEM87A SLC1A5 ARFGAP2 SLC12A4 ARFGAP3 SLC20A2 TMEM209 | 2.96e-04 | 246 | 174 | 9 | int:TMEM216 |
| Interaction | JUP interactions | NPM1 ARHGAP24 ERCC3 NCK1 CHD3 ECT2 USP20 FASN IARS2 PTPRF PTPRQ PLEC CDH8 | 3.13e-04 | 485 | 174 | 13 | int:JUP |
| Interaction | RAC1 interactions | PALD1 ITCH PPFIBP1 GOLGA8R NCK1 ECT2 SLC1A5 SLC7A2 FASN PTPN13 DST PTPRF SLC12A4 PTPRG PTPRM PTPRS SLC20A2 TMEM209 IL1RAP IQGAP3 PACSIN2 | 3.45e-04 | 1063 | 174 | 21 | int:RAC1 |
| Interaction | MST1R interactions | 3.55e-04 | 200 | 174 | 8 | int:MST1R | |
| Interaction | STX4 interactions | COPA PPFIBP1 SYNE1 LARS1 SLC1A5 ARFGAP2 SLC7A2 TSPAN31 ARFGAP3 SLC20A2 TMEM209 USP33 | 3.57e-04 | 428 | 174 | 12 | int:STX4 |
| Interaction | AURKA interactions | NPM1 EPRS1 COPA U2SURP GOLGA8R TRRAP USP20 PTPN5 FASN PTPRD PIK3CB USP40 TNFAIP3 PACSIN2 USP33 SORL1 | 3.62e-04 | 696 | 174 | 16 | int:AURKA |
| Interaction | HUNK interactions | 3.69e-04 | 109 | 174 | 6 | int:HUNK | |
| Interaction | KHDRBS1 interactions | EPRS1 ARHGAP24 COPA NCK1 CHD3 ECT2 TRRAP PTPN6 FASN PLEC PACSIN2 | 4.12e-04 | 373 | 174 | 11 | int:KHDRBS1 |
| Interaction | OCLN interactions | ITCH PPFIBP1 TMEM87A SLC1A5 CHRNA4 SLC7A2 PTPN13 DST PTPRG USP40 ZER1 TNFAIP3 PACSIN2 | 4.18e-04 | 500 | 174 | 13 | int:OCLN |
| Interaction | RAB5A interactions | PPFIBP1 TMEM87A SLC1A5 NLRP3 ARFGAP2 SLC7A2 DST SLC12A4 PIK3CB ARFGAP3 SLC20A2 TMEM209 SNX1 DYNC1H1 PACSIN2 USP33 | 4.23e-04 | 706 | 174 | 16 | int:RAB5A |
| Interaction | PCDHB16 interactions | 4.24e-04 | 41 | 174 | 4 | int:PCDHB16 | |
| Interaction | DHX15 interactions | NPM1 EPRS1 RANBP2 ARHGAP24 NLRP7 U2SURP LARS1 CHD3 ECT2 TRRAP FASN WDR12 DYNC1H1 | 4.34e-04 | 502 | 174 | 13 | int:DHX15 |
| Interaction | RAB35 interactions | PALD1 PPFIBP1 TMEM87A SLC1A5 SLC7A2 PTPN13 DST PTPRF SLC12A4 PTPRG PTPRS SLC20A2 TMEM209 PACSIN2 | 4.68e-04 | 573 | 174 | 14 | int:RAB35 |
| Interaction | LGR4 interactions | 4.69e-04 | 262 | 174 | 9 | int:LGR4 | |
| Interaction | AGR2 interactions | NPM1 EPRS1 COPA COPB1 SYNE1 LARS1 CHD8 SLC1A5 USP20 EPG5 DNAH1 RTKN2 FASN IARS2 DST EIF5B PLEC IQGAP3 DYNC1H1 | 4.70e-04 | 934 | 174 | 19 | int:AGR2 |
| Interaction | SPTLC1 interactions | 4.70e-04 | 159 | 174 | 7 | int:SPTLC1 | |
| Cytoband | 2q13 | 1.53e-04 | 68 | 180 | 4 | 2q13 | |
| Cytoband | 1p32.2 | 2.27e-04 | 6 | 180 | 2 | 1p32.2 | |
| Cytoband | 4q13.2 | 2.46e-04 | 31 | 180 | 3 | 4q13.2 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | PTPRT PTPRA PTPRB PTPRD PTPRE PTPRF PTPRG PTPRM PTPRR PTPRS PTPRQ | 7.42e-19 | 21 | 133 | 11 | 813 |
| GeneFamily | Fibronectin type III domain containing | IL31RA PTPRT CNTN6 PTPRB PTPRD PTPRF PTPRG PTPRM PTPRS PTPRQ SORL1 | 2.75e-08 | 160 | 133 | 11 | 555 |
| GeneFamily | Dyneins, axonemal | 6.18e-06 | 17 | 133 | 4 | 536 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.12e-05 | 8 | 133 | 3 | 939 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.05e-04 | 13 | 133 | 3 | 1186 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.07e-04 | 115 | 133 | 6 | 769 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 2.93e-04 | 18 | 133 | 3 | 812 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 3.46e-04 | 19 | 133 | 3 | 131 | |
| GeneFamily | PRAME family | 7.03e-04 | 24 | 133 | 3 | 686 | |
| GeneFamily | Fatty acid desaturases | 1.46e-03 | 8 | 133 | 2 | 553 | |
| GeneFamily | UDP glucuronosyltransferases | 1.65e-03 | 32 | 133 | 3 | 363 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | SMG1 EPRS1 RANBP2 ABCA3 COPA PPFIBP1 SPIRE1 PTPRB DST SLC12A4 PTPRR MICAL2 TNFAIP3 IL1RAP MMP16 | 1.60e-06 | 495 | 178 | 15 | M8451 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.78e-06 | 33 | 178 | 5 | MM477 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN | 7.60e-06 | 194 | 178 | 9 | M5393 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | RANBP2 ITCH RGPD8 COPA RRP1B U2SURP AXIN2 POLR3E TNFAIP3 CENATAC HECA SORL1 RGPD5 | 8.74e-06 | 432 | 178 | 13 | M41149 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.07e-05 | 43 | 178 | 5 | MM3857 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 1.66e-05 | 79 | 178 | 6 | M7102 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP | 1.95e-05 | 167 | 178 | 8 | M365 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 SMG1 RANBP2 RGPD8 PPFIBP1 RGPD1 EPG5 DNAH1 ZSWIM9 RGPD3 GKAP1 HECA RGPD5 | 2.32e-05 | 474 | 178 | 13 | M40991 |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 2.97e-05 | 177 | 178 | 8 | M9401 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 RANBP2 RGPD8 PPFIBP1 RGPD1 TMEM229B AREL1 PTPRD SLC12A4 RGPD3 GCA TNFAIP3 | 4.55e-05 | 435 | 178 | 12 | MM1221 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 5.94e-05 | 313 | 178 | 10 | M40228 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_UP | 6.56e-05 | 198 | 178 | 8 | M9245 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 6.80e-05 | 199 | 178 | 8 | M6992 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_2D_DN | 6.98e-05 | 63 | 178 | 5 | M7615 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN | 7.04e-05 | 200 | 178 | 8 | M6585 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN | 7.04e-05 | 200 | 178 | 8 | M4066 | |
| Coexpression | GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP | 7.04e-05 | 200 | 178 | 8 | M5763 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.24e-04 | 71 | 178 | 5 | M2948 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GALNT10 ABCA3 SYNE1 AQP4 TMEM87A FASN PTPN13 FADS1 PTPRG KCNJ15 FADS2 | 5.57e-10 | 199 | 179 | 11 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | ABCA3 SYNE1 SPIRE1 SLC7A2 FASN PTPN13 PTPRD PTPRG MICAL2 KCNJ15 | 3.29e-09 | 180 | 179 | 10 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA3 SYNE1 SPIRE1 SLC7A2 FASN PTPN13 PTPRD PTPRG MICAL2 KCNJ15 | 6.42e-09 | 193 | 179 | 10 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA3 SYNE1 SPIRE1 SLC7A2 FASN PTPN13 PTPRD PTPRG MICAL2 KCNJ15 | 6.42e-09 | 193 | 179 | 10 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-08 | 168 | 179 | 9 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.95e-08 | 169 | 179 | 9 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-08 | 187 | 179 | 9 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-08 | 187 | 179 | 9 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.65e-08 | 194 | 179 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-07 | 195 | 179 | 9 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-07 | 195 | 179 | 9 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-07 | 195 | 179 | 9 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-07 | 197 | 179 | 9 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-07 | 198 | 179 | 9 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-07 | 179 | 179 | 8 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-07 | 182 | 179 | 8 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-07 | 182 | 179 | 8 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-07 | 182 | 179 | 8 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-07 | 182 | 179 | 8 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-07 | 183 | 179 | 8 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.26e-07 | 184 | 179 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 8.26e-07 | 184 | 179 | 8 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.26e-07 | 184 | 179 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.61e-07 | 185 | 179 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.61e-07 | 185 | 179 | 8 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.33e-07 | 187 | 179 | 8 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 9.33e-07 | 187 | 179 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-06 | 189 | 179 | 8 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-06 | 190 | 179 | 8 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.14e-06 | 192 | 179 | 8 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | moderate-Myeloid-Neutrophil|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-06 | 192 | 179 | 8 | 8105408400dac5dcb0ce62b558433257559c9f09 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 193 | 179 | 8 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-06 | 194 | 179 | 8 | eb9656d6d2da9aa074e6f5c06d750a6f9828208a | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-06 | 195 | 179 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-06 | 196 | 179 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 196 | 179 | 8 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.33e-06 | 196 | 179 | 8 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-06 | 197 | 179 | 8 | 42e49a8ce3118db6c2fd620d70c480b75143c828 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-06 | 197 | 179 | 8 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-06 | 197 | 179 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.43e-06 | 198 | 179 | 8 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | 343B-Epithelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-06 | 198 | 179 | 8 | 0756a5d01572343abce77e7584b816c2c2e9d9c7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-06 | 199 | 179 | 8 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 1.49e-06 | 199 | 179 | 8 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-06 | 199 | 179 | 8 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 1.49e-06 | 199 | 179 | 8 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-06 | 199 | 179 | 8 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-06 | 199 | 179 | 8 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-06 | 199 | 179 | 8 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | ASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.49e-06 | 199 | 179 | 8 | ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 1.49e-06 | 199 | 179 | 8 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.49e-06 | 199 | 179 | 8 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.40e-06 | 168 | 179 | 7 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-06 | 169 | 179 | 7 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 5.84e-06 | 170 | 179 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-06 | 173 | 179 | 7 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-06 | 173 | 179 | 7 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 6.80e-06 | 174 | 179 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 176 | 179 | 7 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.61e-06 | 177 | 179 | 7 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.19e-06 | 179 | 179 | 7 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.19e-06 | 179 | 179 | 7 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.49e-06 | 180 | 179 | 7 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.49e-06 | 180 | 179 | 7 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.49e-06 | 180 | 179 | 7 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 182 | 179 | 7 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 182 | 179 | 7 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 9.45e-06 | 183 | 179 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.45e-06 | 183 | 179 | 7 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 183 | 179 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-06 | 183 | 179 | 7 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.45e-06 | 183 | 179 | 7 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 9.45e-06 | 183 | 179 | 7 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 184 | 179 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 184 | 179 | 7 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 184 | 179 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 9.80e-06 | 184 | 179 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 184 | 179 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-05 | 186 | 179 | 7 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 186 | 179 | 7 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 186 | 179 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.05e-05 | 186 | 179 | 7 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-05 | 186 | 179 | 7 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 186 | 179 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 187 | 179 | 7 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 187 | 179 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.09e-05 | 187 | 179 | 7 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.13e-05 | 188 | 179 | 7 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.13e-05 | 188 | 179 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.13e-05 | 188 | 179 | 7 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 188 | 179 | 7 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.17e-05 | 189 | 179 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 190 | 179 | 7 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 190 | 179 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.21e-05 | 190 | 179 | 7 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-05 | 191 | 179 | 7 | 6cb2c107bc674aa173b4009f320a1687a76f3979 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 191 | 179 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.25e-05 | 191 | 179 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-05 | 192 | 179 | 7 | 545c3990cbe3c04bfd95a0ab7499d2c4af509be1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-05 | 192 | 179 | 7 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| Drug | 2-(oxalylamino)benzoic acid | 5.41e-10 | 7 | 176 | 5 | ctd:C405943 | |
| Drug | uridine 5'-diphosphoglucuronic acid | COPB1 AQP4 SLC1A5 POLR3E TK2 UGT2B10 EIF5B GCA UGT2B28 UGT2B11 | 2.25e-06 | 189 | 176 | 10 | CID000000390 |
| Disease | phosphatidylcholine acyl-alkyl C36:5 measurement | 1.83e-06 | 5 | 169 | 3 | EFO_0801293 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.98e-06 | 18 | 169 | 4 | EFO_0010382 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 3.65e-06 | 6 | 169 | 3 | EFO_0801920 | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4) measurement | 3.65e-06 | 6 | 169 | 3 | EFO_0800394 | |
| Disease | 1-(1-enyl-palmitoyl)-GPC (P-16:0) measurement | 3.65e-06 | 6 | 169 | 3 | EFO_0800323 | |
| Disease | 1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)* measurement | 3.65e-06 | 6 | 169 | 3 | EFO_0020014 | |
| Disease | X-24870 measurement | 6.35e-06 | 7 | 169 | 3 | EFO_0022143 | |
| Disease | level of Sterol ester (27:1/22:6) in blood serum | 6.35e-06 | 7 | 169 | 3 | OBA_2045201 | |
| Disease | level of Phosphatidylcholine (O-18:2_20:4) in blood serum | 6.35e-06 | 7 | 169 | 3 | OBA_2045135 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement | 1.01e-05 | 8 | 169 | 3 | EFO_0800423 | |
| Disease | 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) measurement | 1.01e-05 | 8 | 169 | 3 | EFO_0800420 | |
| Disease | urate measurement, bone density | AKAP6 ARHGAP24 PPFIBP1 SYNE1 ETS1 PRSS51 PPL DNAH1 PTPRD PTPRG POLR3E USP40 NXPH2 DNAH11 | 1.44e-05 | 619 | 169 | 14 | EFO_0003923, EFO_0004531 |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 2.15e-05 | 10 | 169 | 3 | EFO_0800507 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement | 2.15e-05 | 10 | 169 | 3 | EFO_0800499 | |
| Disease | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement | 2.15e-05 | 10 | 169 | 3 | EFO_0800402 | |
| Disease | Macrocephaly | 2.94e-05 | 11 | 169 | 3 | C0221355 | |
| Disease | phosphatidylcholine 32:0 measurement | 2.94e-05 | 11 | 169 | 3 | EFO_0010372 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 2.94e-05 | 11 | 169 | 3 | OBA_2045123 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 3.91e-05 | 12 | 169 | 3 | EFO_0800500 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:3) in blood serum | 3.91e-05 | 12 | 169 | 3 | OBA_2045115 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 3.91e-05 | 12 | 169 | 3 | EFO_0800466 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 4.20e-05 | 220 | 169 | 8 | EFO_0004529, EFO_0008317 | |
| Disease | phosphatidylcholine ether measurement | 5.06e-05 | 13 | 169 | 3 | EFO_0010227 | |
| Disease | cholesteryl ester 16:0 measurement | 5.30e-05 | 36 | 169 | 4 | EFO_0010341 | |
| Disease | hippocampal volume | 5.75e-05 | 297 | 169 | 9 | EFO_0005035 | |
| Disease | Parkinson disease, disease progression measurement | 7.30e-05 | 39 | 169 | 4 | EFO_0008336, MONDO_0005180 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 7.98e-05 | 15 | 169 | 3 | EFO_0800508 | |
| Disease | phosphatidylcholine 36:3 measurement | 7.98e-05 | 15 | 169 | 3 | EFO_0010381 | |
| Disease | 1-(1-enyl-palmitoyl)-2-myristoyl-GPC (P-16:0/14:0) measurement | 9.75e-05 | 3 | 169 | 2 | EFO_0800465 | |
| Disease | phosphatidylcholine 38:6 measurement | 9.78e-05 | 16 | 169 | 3 | EFO_0010388 | |
| Disease | triacylglycerol 56:6 measurement | 1.08e-04 | 43 | 169 | 4 | EFO_0010433 | |
| Disease | triacylglycerol 56:3 measurement | 1.41e-04 | 18 | 169 | 3 | EFO_0010430 | |
| Disease | diacylglycerol 36:3 measurement | 1.41e-04 | 18 | 169 | 3 | EFO_0020062 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.67e-04 | 19 | 169 | 3 | EFO_0802076 | |
| Disease | diacylglycerol 38:5 measurement | 1.67e-04 | 19 | 169 | 3 | EFO_0020067 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.94e-04 | 206 | 169 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | Palmitoyl-arachidonoyl-glycerol (16:0/20:4) [2] measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0022103 | |
| Disease | Sphingomyelin (d18:2/14:0, d18:1/14:1) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0022114 | |
| Disease | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0022116 | |
| Disease | 2-arachidonoylglycerol (20:4) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800182 | |
| Disease | 2-linoleoyl-GPC (18:2) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800239 | |
| Disease | 1-dihomo-linoleoyl-GPC (20:2) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800236 | |
| Disease | docosapentaenoate (n6 DPA; 22:5n6) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800249 | |
| Disease | 1-linoleoyl-2-docosahexaenoyl-GPC (18:2/22:6) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0022080 | |
| Disease | 1-margaroyl-2-arachidonoyl-GPC (17:0/20:4) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0022081 | |
| Disease | 1-arachidoyl-2-arachidonoyl-GPC (20:0/20:4) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0022079 | |
| Disease | phosphatidylcholine (O-18:1/20:4, O-16:0/22:5n3) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800553 | |
| Disease | arachidonate 20:4n6-to-dihomo-linolenate 20:3n3 or n6 ratio | 1.94e-04 | 4 | 169 | 2 | EFO_0021517 | |
| Disease | fatty acid measurement, linolenic acid measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0005110, EFO_0006811 | |
| Disease | phosphatidylcholine acyl-alkyl C38:5 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801299 | |
| Disease | phosphatidylcholine acyl-alkyl C36:4 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801292 | |
| Disease | phosphatidylcholine acyl-alkyl C36:2 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801290 | |
| Disease | phosphatidylcholine diacyl C38:5 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801267 | |
| Disease | phosphatidylcholine diacyl C38:4 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801266 | |
| Disease | phosphatidylcholine diacyl C36:4 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801260 | |
| Disease | phosphatidylcholine diacyl C40:6 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801274 | |
| Disease | phosphatidylcholine diacyl C36:3 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801259 | |
| Disease | phosphatidylcholine diacyl C34:4 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801255 | |
| Disease | level of Phosphatidylcholine (O-16:0_22:5) in blood serum | 1.94e-04 | 4 | 169 | 2 | OBA_2045117 | |
| Disease | sphingomyeline C16:1 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0801318 | |
| Disease | 1-linoleoyl-2-linolenoyl-GPC (18:2/18:3) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800483 | |
| Disease | eicosapentaenoylcholine measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800482 | |
| Disease | comprehensive strength index, muscle measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0004515, EFO_0004979 | |
| Disease | 1-stearoyl-2-adrenoyl-GPC (18:0/22:4) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800459 | |
| Disease | 1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800458 | |
| Disease | phosphatidylcholine (18:0/20:5, 16:0/22:5n6) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800468 | |
| Disease | 1-stearoyl-2-meadoyl-GPC (18:0/20:3n9) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800463 | |
| Disease | 1-pentadecanoyl-2-arachidonoyl-GPC (15:0/20:4) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800446 | |
| Disease | 1-palmitoyl-2-alpha-linolenoyl-GPC (16:0/18:3n3) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800442 | |
| Disease | 1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800408 | |
| Disease | phosphatidylcholine 33:2 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0021470 | |
| Disease | phosphatidylcholine 33:1 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0021469 | |
| Disease | 1,2-dilinoleoyl-GPC (18:2/18:2) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800388 | |
| Disease | 1-eicosapentaenoyl-GPC (20:5) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800355 | |
| Disease | 1-(1-enyl-stearoyl)-GPC (P-18:0) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800325 | |
| Disease | 1-(1-enyl-oleoyl)-GPC (P-18:1) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800324 | |
| Disease | 1-lignoceroyl-GPC (24:0) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800322 | |
| Disease | 1-adrenoyl-GPC (22:4) measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800321 | |
| Disease | triglyceride measurement, phospholipid measurement | 2.02e-04 | 146 | 169 | 6 | EFO_0004530, EFO_0004639 | |
| Disease | Colorectal Carcinoma | AKAP6 MPO ABCC3 ABCA3 SYNE1 HTR3C PTPRT AXIN2 FADS1 PTPRD PTPRS FADS2 SORL1 | 2.16e-04 | 702 | 169 | 13 | C0009402 |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.51e-04 | 215 | 169 | 7 | EFO_0008317, EFO_0008591 | |
| Disease | triacylglycerol 54:6 measurement | 2.62e-04 | 22 | 169 | 3 | EFO_0010424 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.99e-04 | 157 | 169 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 3.00e-04 | 23 | 169 | 3 | OBA_2045181 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.22e-04 | 224 | 169 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | 2-arachidonoyl-GPC (20:4) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800237 | |
| Disease | 1-arachidonoyl-GPC (20:4n6) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800234 | |
| Disease | 1-linoleoyl-GPC (18:2) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800223 | |
| Disease | nuclear receptor-binding protein measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0801854 | |
| Disease | fatty acid measurement, docosapentaenoic acid measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0005110, EFO_0006809 | |
| Disease | sphingomyeline C18:1 measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0801320 | |
| Disease | 1-palmitoleoyl-2-linolenoyl-GPC (16:1/18:3) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800484 | |
| Disease | phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800467 | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800415 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800407 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800417 | |
| Disease | 1-linolenoyl-GPE (18:3) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800365 | |
| Disease | 1-(1-enyl-stearoyl)-GPE (P-18:0) measurement | 3.22e-04 | 5 | 169 | 2 | EFO_0800335 | |
| Disease | Malignant neoplasm of stomach | 3.53e-04 | 300 | 169 | 8 | C0024623 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.68e-04 | 229 | 169 | 7 | EFO_0004639, EFO_0008317 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFEDFWRMIWEQNTG | 931 | P23470 | |
| TKDFWRMIWDHNAQI | 1231 | P23470 | |
| SWVEVEAKVQTRNWM | 721 | Q15361 | |
| NIMVAFKGVWTQAFW | 21 | P55087 | |
| WMATDFAQERRWKVA | 821 | Q96L91 | |
| QVWFAWTVLNMESIF | 1231 | Q9HCE0 | |
| QMMTTNVWVKQEWHD | 81 | P43681 | |
| SFNEATMVLVSWIMW | 261 | Q15758 | |
| ITNWEREFNTWTEMN | 871 | Q9HCK8 | |
| ELDSNWSWFQLRCMQ | 66 | Q9NP61 | |
| SWFEPLVEDMQRQWA | 281 | P02649 | |
| ELWAALNAWKENFMT | 116 | P28676 | |
| LVIFTWMEVQRTWSH | 1531 | Q96DT5 | |
| WMEVQRTWSHLESIF | 1536 | Q96DT5 | |
| AAYSWREWKMVAAQV | 916 | Q99758 | |
| SVHWDNNEREKMSPW | 1086 | Q6RI45 | |
| WTKTQLMELWVQFSH | 406 | Q8WXA8 | |
| SQDVWQWMLESERQS | 616 | Q9Y2T1 | |
| WQEWRQRDEQLTSEM | 111 | Q5VSY0 | |
| TELDSNWNWFQLRCM | 66 | Q8N6H7 | |
| MVQLSADTWVRFSIW | 576 | P52569 | |
| MEWSREVTTNAQRWA | 61 | P16562 | |
| WIKFRFQTMDGDWEN | 1111 | Q5H9R4 | |
| MNWDQQALEAWLEES | 136 | Q9UFE4 | |
| SMENFWDWLANITEI | 76 | O95156 | |
| FRMTDQEAIQDLWQW | 276 | P06748 | |
| TLQNMKGTERVWLWT | 2391 | P49792 | |
| IANRWSFEGMDRWIK | 96 | Q8WXH6 | |
| IANRWSFEGMDRWIK | 96 | P0C0E4 | |
| FIMNEKWDTNSSENW | 101 | Q9Y5X5 | |
| LQNMKGTERVWVWTA | 1416 | Q99666 | |
| LQNMKGTERVWVWTA | 1416 | O14715 | |
| VVKQEWFWGSIQMDA | 331 | Q9H8V3 | |
| IVSTVADFWRMVWQE | 376 | P54829 | |
| WLSAWTNDAMADSRQ | 991 | O15438 | |
| EKADSWQRPFSTWMQ | 791 | Q9ULE6 | |
| WQRPFSTWMQEVASK | 796 | Q9ULE6 | |
| MEATVSVFRAHQWQW | 86 | E5RJ46 | |
| TMIVHKNWVDLAWAV | 286 | O95864 | |
| WTMHNAQDLQKWTEE | 1111 | P20585 | |
| GTKDDFWKMVWEQNV | 1781 | P23467 | |
| KQETVNDFWRMVWEQ | 211 | P23469 | |
| NDFWRMVWEQKSATI | 216 | P23469 | |
| HNNTWTWLDFAMAVK | 2151 | Q14667 | |
| SKERSTLWDQMQFWE | 1311 | Q8WXG6 | |
| IWNTMQFLKSCFQWE | 671 | Q6DN12 | |
| KSWWRVRNSMNKTGF | 36 | P16333 | |
| SWWKVMEEDLQSQLL | 296 | Q6ZVK8 | |
| QSSALDVNTWMIEWF | 346 | Q8NI17 | |
| ARSWNEKQCRQNMWT | 151 | Q9UBI9 | |
| PSEVQKWTNHRVMEW | 801 | Q86W92 | |
| KWTNHRVMEWLRSVD | 806 | Q86W92 | |
| SFLMDSRNEVWWTID | 271 | Q9NPH3 | |
| WVKVQMQELSTRWET | 6891 | Q03001 | |
| AWNNMQVFTFTWRED | 496 | Q86SR1 | |
| KWINGMDEQIMSWAT | 3971 | Q15751 | |
| SWIRNSDSFLKMNKW | 321 | Q5H9U9 | |
| WMDKNFDKIRVWLQS | 921 | Q9NZ08 | |
| HVRDWVMWAVNEFSL | 76 | P14921 | |
| NIRAFNAVKNWSWMK | 866 | A7E2Y1 | |
| DWNMFVKLRSQECDW | 1681 | O60437 | |
| DRFWWENEGVFSMQQ | 676 | P05164 | |
| QALAEMDRWQEVLSW | 91 | Q7Z412 | |
| RQMWAEFEWENKVTV | 841 | P53618 | |
| TFWVSEWSTMNPEQR | 371 | Q6ZU69 | |
| TFWVSEWSTMNPEQR | 101 | Q63HN1 | |
| LQDLWTTVIDMKWRY | 51 | Q99712 | |
| ETFRRMWKWLQEPEF | 386 | O95948 | |
| NFVLKWQRSEKRWMD | 691 | Q6ZR08 | |
| MDWNWRILFLVVATT | 1 | P0DTW3 | |
| SQKGAWMDLSIFRQW | 251 | Q9Y4A0 | |
| IQTVRTNFPETWMWD | 716 | Q6IE36 | |
| MRKEVWVALVVASWV | 136 | Q8NGJ1 | |
| QQEWAAVRLQSWVRM | 66 | A8MTL0 | |
| LSEWFDWILRNMDVS | 161 | O00142 | |
| LDAIIKIQAWARMWA | 791 | Q86VI3 | |
| VEQFMKSLWQWHETD | 116 | Q8N8X9 | |
| VGDFWRMVWETRAKT | 2116 | Q9UMZ3 | |
| NTVDDFWQMVWQEDS | 471 | Q15256 | |
| TFGDFWRMVWEQRSA | 1471 | Q13332 | |
| TEDFWRMLWENNSTI | 1761 | Q13332 | |
| ETVKDFWRMIWQENS | 966 | O14522 | |
| FWRMIWQENSASIVM | 971 | O14522 | |
| MMWENWTIVSEFVLV | 1 | Q9H209 | |
| SKQIMWFWQFVKEID | 806 | Q96J02 | |
| WFWQFVKEIDNEKRM | 811 | Q96J02 | |
| MNWPQFEEWSADLNR | 296 | Q9UNF0 | |
| SLQNMKGTERVWVWT | 1416 | A6NKT7 | |
| NDMEDWVKSIRRVIW | 111 | Q8N264 | |
| VFWSRRDKDFALVWM | 221 | O00144 | |
| RSWFDQLLKRCMEQW | 2486 | Q9P2D7 | |
| FQLWQFGRWMDVVVD | 141 | Q6ZSI9 | |
| HKFEWTRMEFQTWAL | 181 | Q5T8I9 | |
| LNREQTDEWKGWMQL | 426 | Q96PB1 | |
| SVEWRAQSEYSWRKM | 211 | P13765 | |
| WVTWMRNEQEQLGTK | 236 | P29017 | |
| ITNWEREFRTWTEMN | 521 | Q8TD26 | |
| TIINWEREFQMWAPK | 796 | Q12873 | |
| DRQVKIWRMNESKAW | 226 | P53621 | |
| IWRMNESKAWEVDTC | 231 | P53621 | |
| WASHQRMKFSTWDRD | 226 | Q08830 | |
| LMWNDWNKEVRRAAA | 671 | Q86WZ0 | |
| KVMRWFWTVVSSLTQ | 731 | O15033 | |
| ASEMEVSWNAIAWNR | 816 | Q9UQ52 | |
| VRFLESNWFVWVTQM | 326 | O60427 | |
| MALFDVWIDVQRRWV | 1531 | Q14204 | |
| SLENWAKAVKRSMNW | 511 | Q6ZS86 | |
| ATNKFWWENKAEVQM | 101 | Q86UT8 | |
| SKRSWMWNQFFLLEE | 51 | P55285 | |
| VEQWKAQFKMWSTID | 371 | P19447 | |
| RGWVWNQMFVLEEFS | 61 | P55286 | |
| FMTLWDFLESWIIQN | 21 | Q8NDH2 | |
| QDMRWVEQLEWSLSK | 271 | I6L899 | |
| GQKFREAWMQFWSET | 536 | Q6UWW8 | |
| LWKDNWVSFMDTMLQ | 1021 | P49327 | |
| TWEFRDEMVNRIWQN | 3366 | Q8IVF4 | |
| QWMELVKIVASWFIS | 136 | Q08357 | |
| VMWKFTQSRWVVRKE | 356 | Q9NVU0 | |
| TKRGWMWNQFFLLEE | 51 | Q9ULB4 | |
| QVQKEEERTWDWCWM | 111 | A0A1B0GVH4 | |
| WKDAFQWMSSRVSPN | 66 | Q14154 | |
| LAAFDTAWMVKSWNQ | 416 | O94851 | |
| GDFWQMIWEQKSTVI | 2291 | Q12923 | |
| VNDFWRMIWEQNTAT | 321 | P18433 | |
| EDFWRMLWEHNSTII | 1721 | P10586 | |
| DFWRMVWHENTASII | 981 | P28827 | |
| EDFWRMLWEHNSTIV | 1726 | P23468 | |
| LQNMKGTERVWVWTA | 1401 | P0DJD0 | |
| FAWLQMETSNERVWI | 1141 | P22897 | |
| KAWAMAVWIFAAINR | 66 | Q96P20 | |
| DNREDLQKWMEAFWQ | 376 | Q8IZC4 | |
| REALQSWMEALWQLF | 401 | Q9BST9 | |
| ELWQATNRWDLMGKE | 126 | Q7L3T8 | |
| VDFSRVRMWSLNNWS | 511 | Q68CQ4 | |
| SLQNMKGTERVWVWT | 1416 | Q7Z3J3 | |
| LWKSDDFGQTWIMIQ | 231 | Q92673 | |
| SRSVVNMEWDKIWAF | 481 | P07814 | |
| QTFWQTMNREWKGID | 96 | Q14684 | |
| DSRMWIEFRSSSNWV | 436 | O43897 | |
| EALQSMWFWVKAIQD | 2631 | Q8NF91 | |
| MWFWVKAIQDRLACA | 2636 | Q8NF91 | |
| TEMQALRADWKQWED | 2921 | Q8NF91 | |
| MFTAAWEFVVNLNWK | 26 | Q8NBD8 | |
| SWKMVESARWLIINN | 276 | Q8N4F4 | |
| DLVMRFNEVSSWVTW | 596 | Q9P212 | |
| RLYTWVEWVKEMVAN | 766 | Q9P2J5 | |
| VEWVKEMVANWDSLR | 771 | Q9P2J5 | |
| WDAQKRATMRVWQAN | 771 | Q9NTG1 | |
| MVANSFRNKLWNWEK | 131 | Q5VWT5 | |
| DWFRDEMQKSDWQLI | 1196 | O60841 | |
| FQKHRIEQWKTWMEE | 2656 | Q96Q15 | |
| QDVSENFWMVWSEAM | 106 | Q5VT98 | |
| EGWRNSMEKQSLVWK | 121 | Q8WX94 | |
| LQAFWQTMNREWTGI | 96 | P56182 | |
| KSAFIRWGIMADWNN | 196 | Q9NSE4 | |
| AFKRDLNWNTWGMFT | 1121 | P14410 | |
| ESWTTKVNWMAHTVR | 1051 | P42338 | |
| LEMLRDQLAKWQWET | 461 | P51688 | |
| QMTWTRDKYMTETWD | 981 | Q9UP95 | |
| FKQRVMTCFRAWEDW | 646 | O15042 | |
| FIQWLNEAMETTENW | 791 | Q13023 | |
| IMTLNVEEWATAWKV | 31 | Q17RA5 | |
| MDKNGTMTIDWNEWR | 126 | Q6KCM7 | |
| QDVCENFWMVWSEAM | 106 | Q5VXH4 | |
| DQVMEFSWSALWNIT | 541 | Q7Z7L7 | |
| ERMWAAIQSWDINSR | 661 | Q7Z7L7 | |
| IWRGAQMEKEWARAL | 486 | Q86XI8 | |
| QMEKEWARALETRDW | 491 | Q86XI8 | |
| WEISRQIHEFMTWTQ | 411 | Q8N9B8 | |
| KDQWFWRVRNNRVMD | 361 | P51512 | |
| TRNWNDEWDNLIKMA | 161 | P21580 | |
| VRAAFDQRMKTWQRW | 406 | Q13596 | |
| DQRMKTWQRWQDAQA | 411 | Q13596 | |
| WDWLEQNIMKTLSVF | 91 | Q0IIM8 | |
| NADWARFWVQVMRDL | 266 | Q08AE8 | |
| VKVWEADWQIRMVFV | 316 | A6NE52 | |
| QDVCENFWMVWSEAM | 106 | Q5TYX0 | |
| RSKQTDVINASWWVM | 101 | Q12999 | |
| DVINASWWVMSNKTR | 106 | Q12999 | |
| GDVVKTWRFSNMRQW | 586 | Q86UX7 | |
| ESFQAALQTQWSWML | 831 | Q15149 | |
| GKADIWLMRNSWSFQ | 251 | O75310 | |
| SMQWFREWEAFVKGK | 821 | Q9Y2K6 | |
| TVNDFWQMAWQENSR | 331 | P29350 | |
| WQMAWQENSRVIVMT | 336 | P29350 | |
| HMDSWTAKFRNWINE | 331 | Q96SK2 | |
| KSWFVQFPWLIMNEE | 141 | O60290 | |
| TFRIAKCQSDWMERW | 416 | Q96K49 | |
| KADIWLMRNSWNFKF | 251 | P36537 | |
| KRIFSWMQTNNSSHW | 481 | Q6R2W3 | |
| MVWDENLAKSAEAWA | 91 | O43692 | |
| MKKAAVWTDSRYWTQ | 106 | O43895 | |
| ASMDQTILLWEWNVE | 161 | Q9GZL7 | |
| GKADIWLMRNSWSFQ | 251 | Q9BY64 | |
| WLVMTFWLVAQQSDI | 216 | Q6UX68 | |
| WVTSMNEIDWLHVKN | 741 | Q9NVE5 | |
| AWRVSNWTAMKEALV | 2856 | Q9Y4A5 | |
| VQCMRWIFENWRLDA | 91 | Q702N8 | |
| SMQWFREWESFVKGK | 851 | Q8TEY7 | |
| WTTMKFRIVTCQSDW | 421 | Q8NBN3 | |
| WESVANEEMWQARMK | 581 | Q9NX78 | |
| ALRVFWKSREWNMKT | 6 | A8MPX8 |